181 related articles for article (PubMed ID: 30776499)
1. Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells.
Faraahi Z; Baud'huin M; Croucher PI; Eaton C; Lawson MA
Bone; 2019 May; 122():82-92. PubMed ID: 30776499
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
Wei XF; Chen QL; Fu Y; Zhang QK
J Cell Biochem; 2019 Apr; 120(4):6515-6527. PubMed ID: 30450775
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease.
Gooding S; Olechnowicz SWZ; Morris EV; Armitage AE; Arezes J; Frost J; Repapi E; Edwards JR; Ashley N; Waugh C; Gray N; Martinez-Hackert E; Lim PJ; Pasricha SR; Knowles H; Mead AJ; Ramasamy K; Drakesmith H; Edwards CM
Nat Commun; 2019 Oct; 10(1):4533. PubMed ID: 31586071
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the dual Bmp/Wnt inhibitor Sostdc1 enhances pancreatic islet function.
Henley KD; Gooding KA; Economides AN; Gannon M
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E752-61. PubMed ID: 22829579
[TBL] [Abstract][Full Text] [Related]
7. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.
Oshima T; Abe M; Asano J; Hara T; Kitazoe K; Sekimoto E; Tanaka Y; Shibata H; Hashimoto T; Ozaki S; Kido S; Inoue D; Matsumoto T
Blood; 2005 Nov; 106(9):3160-5. PubMed ID: 16030194
[TBL] [Abstract][Full Text] [Related]
8. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
9. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
Giuliani N; Morandi F; Tagliaferri S; Lazzaretti M; Donofrio G; Bonomini S; Sala R; Mangoni M; Rizzoli V
Cancer Res; 2007 Aug; 67(16):7665-74. PubMed ID: 17702698
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of osteoblast differentiation by a novel osteogenic compound, DMP-PYT, through activation of both the BMP and Wnt pathways.
Bae SJ; Kim HJ; Won HY; Min YK; Hwang ES
Sci Rep; 2017 Aug; 7(1):8455. PubMed ID: 28814721
[TBL] [Abstract][Full Text] [Related]
11. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
[TBL] [Abstract][Full Text] [Related]
12. Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model.
Park BM; Kim EJ; Nam HJ; Zhang D; Bae CH; Kang M; Kim H; Lee W; Bogen B; Lim SK
Yonsei Med J; 2017 May; 58(3):505-513. PubMed ID: 28332354
[TBL] [Abstract][Full Text] [Related]
13. Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells.
Collette NM; Yee CS; Hum NR; Murugesh DK; Christiansen BA; Xie L; Economides AN; Manilay JO; Robling AG; Loots GG
Bone; 2016 Jul; 88():20-30. PubMed ID: 27102547
[TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
15. A human bone morphogenetic protein antagonist is down-regulated in renal cancer.
Blish KR; Wang W; Willingham MC; Du W; Birse CE; Krishnan SR; Brown JC; Hawkins GA; Garvin AJ; D'Agostino RB; Torti FM; Torti SV
Mol Biol Cell; 2008 Feb; 19(2):457-64. PubMed ID: 18032587
[TBL] [Abstract][Full Text] [Related]
16. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
Edwards CM; Edwards JR; Lwin ST; Esparza J; Oyajobi BO; McCluskey B; Munoz S; Grubbs B; Mundy GR
Blood; 2008 Mar; 111(5):2833-42. PubMed ID: 18094333
[TBL] [Abstract][Full Text] [Related]
17. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
[TBL] [Abstract][Full Text] [Related]
20. rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair.
Minear S; Leucht P; Miller S; Helms JA
J Bone Miner Res; 2010 Jun; 25(6):1196-207. PubMed ID: 20200943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
